Nutritional compositions containing a peptide component and uses thereof

Patent metadata

Field	Value
Publication number	US-9345727-B2
Application number	US-201313832958-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	Mar 15, 2013
Publication date	May 24, 2016
Grant date	May 24, 2016

Abstract

The present disclosure relates to nutritional compositions including a protein equivalent source including a peptide component comprising selected peptides from Tables 1 and 2 disclosed herein. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the incidence of autoimmune disease and/or diabetes mellitus by providing said nutritional compositions to a target subject, which includes a pediatric subject.

First claim

What is claimed is:

1. A nutritional composition comprising:
(i) a carbohydrate;
(ii) a fat; and
(iii) a protein equivalent, wherein
a) at least 20% of the protein equivalent includes an extensively hydrolyzed protein, wherein the extensively hydrolyzed protein consists of the following individual peptides: SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, SEQ ID NO 63, SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, SEQ ID NO 8, SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 14; and
b) 20% to 80% of the protein equivalent comprises a partially hydrolyzed protein, amino acids, or combinations thereof.

2. The nutritional composition of claim 1 , wherein the peptide component is present in an amount from about 0.2 g/100 kcals to about 5.6 g/100 kcals.

3. The nutritional composition of claim 1 , wherein the peptide component further comprises at least 10 additional individual peptides selected from the group consisting of SEQ ID NO 15, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 25, SEQ ID NO 26, SEQ ID NO 27, SEQ ID NO 28, SEQ ID NO 29, SEQ ID NO 33, SEQ ID NO 34, SEQ ID NO 35, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38, SEQ ID NO 39, SEQ ID NO 40, SEQ ID NO 41, SEQ ID NO 42, SEQ ID NO 43, SEQ ID NO 44, SEQ ID NO 45, SEQ ID NO 46, SEQ ID NO 47, SEQ ID NO 48, SEQ ID NO 49, SEQ ID NO 50, SEQ ID NO 52, SEQ ID NO 53, SEQ ID NO 54, SEQ ID NO 55, SEQ ID NO 56, SEQ ID NO 58, SEQ ID NO 59, SEQ ID NO 61, SEQ ID NO 62, SEQ ID NO 64 and combinations thereof.

4. The nutritional composition of claim 1 , wherein the partially hydrolyzed protein has a degree of hydrolysis of less than 40% and further wherein the protein equivalent comprises casein hydrolysate having a molar mass distribution of greater than 500 Daltons.

5. The nutritional composition of claim 1 , further comprising at least one long-chain polyunsaturated fatty acid.

6. The nutritional composition of claim 5 , wherein the at least one long-chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid and arachidonic acid.

7. The nutritional composition of claim 1 , further comprising a culture supernatant from a late-exponential growth phase of a probiotic batch-cultivation process.

8. The nutritional composition of claim 1 , further comprising a probiotic.

9. The nutritional composition of claim 1 , further comprising a prebiotic.

10. The nutritional composition of claim 1 , wherein when administered to a subject, the nutritional composition reduces the incidence of autoimmune disease.

11. The composition of claim 1 , wherein the nutritional composition further comprises intact protein.

Assignees

• Mead Johnson Nutrition Co

Inventors

• Hondmann Dirk
• Van Tol Eric A F
• Gross Gabriele
• Schoemaker Marieke H
• Lambers Teartse Tim

Classifications

• A61K38/08

  Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

• A23L33/18

  Peptides; Protein hydrolysates · CPC title

• A61K31/202

  having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title

• A23L33/21

  Addition of substantially indigestible substances, e.g. dietary fibres · CPC title

• A61K38/07

  Tetrapeptides · CPC title